A Decade of Collaboration - AusBiotech and Korean Health Industry Development Institute sign MoU
30 Oct 2024
AusBiotech and the Korea Health Industry Development Institute (KHIDI) today signed a memorandum of understanding (MOU) establishing a framework for collaboration and cooperation that will support the growing biotechnology industry in Australia and Korea.
This milestone marks a decade of collaboration between the two organisations, both of which are thrilled to continue their productive and supportive partnership. Signed on the opening day of AusBiotech’s 2024 Conference—the leading biotech event in the Asia-Pacific—the MOU underscores the essential role of international cooperation in advancing global biotechnology ecosystems.
The MOU recognises the key role that biotechnology plays in national economic and social development, and the significant benefits of partnering internationally to support and accelerate industry advancement. It has been signed by KHIDI Present Dr Soon-do Cha, and AusBiotech CEO Rebekah Cassidy.
Rebekah Cassidy, CEO of AusBiotech, commented:
“I am immensely proud to be continuing this decade-long partnership with KHIDI. Innovation is not constrained by borders and, indeed, is enhanced by international collaboration. By working with KHIDI, we can provide opportunities and support to our members.
“The world is changing, and the need for organisations representing some of the world’s most impactful innovations to be agile to change is paramount. Today’s signing highlights how both of our organisations are embracing more strategic roles that extend beyond national borders, actively contributing to the global life sciences sector.
“In the face of this change, from global pressures – pandemics, supply chain challenges, aging populations, climate change, and more - Australia’s ability to strategically leverage its health and medical research strengths to grow and sustain a thriving life sciences sector is important.
“I also thank KHIDI for being present during AusBiotech 2024, we are grateful and value your attendance”.
-ENDS-
Media enquiries: Emma Boscheinen, Director of Communications, AusBiotech,
eboscheinen@ausbiotech.org / M: +61 (0) 437 075 209
About AusBiotech:
AusBiotech is Australia's leading national and global advocate for life sciences, working to help its more than 3000 members thrive by shaping policy, creating connections, and fostering knowledge sharing. With an unrivalled national convening power, AusBiotech supports its members’ growth by building an Australian life sciences ecosystem that leads in development and commercialisation, creating high-quality, innovative life sciences companies.